🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

@Clavikul Cátia Gaspar Andres F. Cardona Lahey Hospital Douglas E Wood National Comprehensive Cancer Network (NCCN) Because as Douglas E Wood has point out… With current USPSTF guidelines, if you enter lung cancer screening and quit smoking at age 50, then the only way to qualify for screening beyond age 65 (a peak age group for lung cancer) would be to start smoking again!! 🤯🤯🤦🏼‍♂️🤦🏼‍♂️

Best part of the Belsey! Mark Ferguson Lucia Madariaga donington Brian Mitzman Andrew R Brownlee MD FACS UChicago CT Surgery

Extremely proud of our trauma surgery colleagues UChicago Surgery. Phenomenal surgeons and humans—THIS is what taking care of the whole patient looks like. Not just the physical injuries.

Nice paper in The Annals of Thoracic Surgery this morning: Impressive differential risk of LN mets in patients with solid vs. mixed GGO less than 2cm who are clin. node neg. Check out those odds ratios! #lcsm #tssmn CTSurgSocMedNetwork annalsthoracicsurgery.org/article/S0003-…

Awesome lecture, incredible visit. Impossible not to be inspired!!

And always beware the diaspora of responsibility!

Awesome presentation highlighting important work by Jack Kent Lucia Madariaga looking at the cost-effectiveness of ex-vivo lung perfusion for patients undergoing lung transplantation #STS2023 UChicago Surgery UChicago Surgery Residents UChicago CT Surgery

Dr Altorki presenting his ‘labor of love’ CALGB 140503. For peripheral T1a, surgical outcomes, disease free and overall survival not statistically different looking at lobar vs sublobar. Important to note recurrence is 30% for both groups! More data coming at the AATS! #STS2023

I am incredibly appreciative to be at an institution that values diversity and equity. I am proud of the work we do to combat structural racism and improve access to care. UChicago Surgery promotes a positive and inclusive environment

@esinghimd Aakash Desai, MD, MPH, FASCO FDA Oncology @DrSteveMartin Nathan A. Pennell MD, PhD, FASCO H. Jack West, MD, FASCO Here’s some help: just do neoadj and you’ll hardly ever have to think about this adj business. The real question is whether there’s value in adj IO for patients who received neoadj chemo-IO. That’s the real question for which we will soon have some useful data. #LCSM

Dr John Alverdy’s last day in the OR after 30 years at UChicago Surgery Thousands of patients have benefited from his expertise, and his legacy includes hundreds of trainees - THE BEST. #ThankYou UChicago Medicine #EndOfAnEra #TheLegend #NewChapter #HesNotGoingAnywhere

Importantly, for clinical relevance, we show that we can predict recurrence after surgery in a cohort of Stage 1A-B lung cancer patients by using machine learning and as a result can inform on adjuvant treatment strategies. We don’t need 35 markers- we can do this with just 6! 🙌🏼

AUDARA update with longer F/U but OS data still withheld ascopubs.org/doi/pdf/10.120… Interesting👀 Brain mets incidence starts to rise AFTER 3 years osi is up in stage II/IIIA while in control group it plateaus at ~10%. So does osi really only delay recurrence?🧐 Do we need MRIs???

Here here! Congratulations Jeff Matthews MD! So well deserved.

Delighted to announce MARS 2 data is now mature and we aim to report this year! Thank you to our patients, UK investigators, Bristol Trials Centre, National Institute for Health and Care Research Science and Innovation at Cancer Research UK for 7 years of hard work!!

💯 Well said. Couldn’t agree more. #tssmn #MedEd #SurgEd

Thank you for sharing your experience! Hearing my patients’ stories over the years during surveillance has led me to believe (even though i cannot prove) that PFTs have value in risk-stratification, but they do not predict patient experience.

5 year follow up from a 2018 phase-II pilot study of neoadj. nivolumab (nejm.org/doi/full/10.10…). Impressive outcomes! aacr.org/about-the-aacr…

Aren’t You the Valet? Tales of Black American Surgeons | NEJM Today, in the US, it is as if there are 2 different scripts being loudly declaimed trying to drown each other out. The escalating chant “BLM” is countered by … cancel culture & White supremacy. nejm.org/doi/full/10.10…